{"id":"https://openalex.org/W2041263286","doi":"https://doi.org/10.1177/1947601912462126","title":"The Ins and Outs of Bcr-Abl Inhibition","display_name":"The Ins and Outs of Bcr-Abl Inhibition","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W2041263286","doi":"https://doi.org/10.1177/1947601912462126","mag":"2041263286","pmid":"https://pubmed.ncbi.nlm.nih.gov/23226582","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3513788"},"language":"en","primary_location":{"id":"doi:10.1177/1947601912462126","doi":"https://doi.org/10.1177/1947601912462126","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1947601912462126","pdf_url":null,"source":{"id":"https://openalex.org/S47803330","display_name":"Genes & Cancer","issn_l":"1947-6019","issn":["1947-6019","1947-6027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes &amp; Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2041263286"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3513788/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108787346","display_name":"E. Premkumar Reddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. P. Reddy","raw_affiliation_strings":["Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089487345","display_name":"Aneel K. Aggarwal","orcid":"https://orcid.org/0000-0003-4389-0173","observed_orcids":["https://orcid.org/0000-0003-4389-0173"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. K. Aggarwal","raw_affiliation_strings":["Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA","#N#            2Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"#N#            2Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089487345"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":null,"apc_paid":null,"fwci":3.1452,"has_fulltext":false,"cited_by_count":140,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91968666,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"3","issue":"5-6","first_page":"447","last_page":"454"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.7649999856948853},{"id":"https://openalex.org/keywords/abl-kinase-inhibitors","display_name":"ABL kinase inhibitors","score":0.8740000128746033},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.921999990940094},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9430000185966492},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9079999923706055},{"id":"https://openalex.org/keywords/kinase-conformation","display_name":"kinase conformation","score":0.6489999890327454},{"id":"https://openalex.org/keywords/p-loop","display_name":"P-loop","score":0.9449999928474426},{"id":"https://openalex.org/keywords/activation-loop","display_name":"activation loop","score":0.968999981880188},{"id":"https://openalex.org/keywords/dfg-motif","display_name":"DFG motif","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inhibitor-binding","display_name":"inhibitor binding","score":0.6899999976158142},{"id":"https://openalex.org/keywords/kinase-inhibitor-design","display_name":"kinase inhibitor design","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9168264865875244},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.8988101482391357},{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.8787508010864258},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.8483012914657593},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7485359907150269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5997518301010132},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5411943197250366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4728917181491852},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3970463275909424},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.336792528629303},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2881143093109131},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2116122841835022},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1606960892677307},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11246806383132935}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1177/1947601912462126","doi":"https://doi.org/10.1177/1947601912462126","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1947601912462126","pdf_url":null,"source":{"id":"https://openalex.org/S47803330","display_name":"Genes & Cancer","issn_l":"1947-6019","issn":["1947-6019","1947-6027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes &amp; Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3513788","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3513788/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes Cancer","raw_type":"Text"},{"id":"pmid:23226582","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23226582","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes & cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3513788","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3513788/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Genes Cancer","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2172041681","display_name":"Novel Substrate Competitive Bcr-Abl Inhibitor Active Against Gleevec-Resistant CM","funder_award_id":"R01HL080666","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1510546584","https://openalex.org/W1965260090","https://openalex.org/W1971651191","https://openalex.org/W1991683855","https://openalex.org/W1994309500","https://openalex.org/W1999614615","https://openalex.org/W2000390423","https://openalex.org/W2003973314","https://openalex.org/W2005515343","https://openalex.org/W2012238745","https://openalex.org/W2015616444","https://openalex.org/W2031594339","https://openalex.org/W2041004110","https://openalex.org/W2043789128","https://openalex.org/W2048411595","https://openalex.org/W2053310263","https://openalex.org/W2054251966","https://openalex.org/W2066998725","https://openalex.org/W2067405360","https://openalex.org/W2075786831","https://openalex.org/W2076500257","https://openalex.org/W2079620307","https://openalex.org/W2092606584","https://openalex.org/W2095675477","https://openalex.org/W2101390452","https://openalex.org/W2101635775","https://openalex.org/W2107268345","https://openalex.org/W2110648386","https://openalex.org/W2112716376","https://openalex.org/W2122367401","https://openalex.org/W2124196948","https://openalex.org/W2126129237","https://openalex.org/W2131174104","https://openalex.org/W2131476854","https://openalex.org/W2132334410","https://openalex.org/W2137601120","https://openalex.org/W2146928870","https://openalex.org/W2156973770","https://openalex.org/W2161835431","https://openalex.org/W2164242115","https://openalex.org/W2165537263"],"related_works":["https://openalex.org/W2076271269","https://openalex.org/W1999512536","https://openalex.org/W2081350174","https://openalex.org/W1975268506","https://openalex.org/W4241137555","https://openalex.org/W2008952509","https://openalex.org/W69628946","https://openalex.org/W2808764596","https://openalex.org/W1979107490","https://openalex.org/W2036026697"],"abstract_inverted_index":{"The":[0],"development":[1],"of":[2,13,29,36,48,58,100,117,130,143,152],"inhibitors":[3,53,78],"against":[4,56],"Abl":[5,63,101,144],"has":[6,41],"changed":[7],"the":[8,11,24,46,59,62,90,98,113,128,131,133,136],"landscape":[9],"for":[10,31,45,112],"treatment":[12,47],"chronic":[14],"myelogenous":[15],"leukemia":[16],"(CML)":[17],"and":[18,27,39,76,82,115,139],"cancer":[19],"in":[20,61,127,148],"general.":[21],"Beginning":[22],"with":[23,87,103],"monumental":[25],"discovery":[26],"approval":[28,44],"imatinib":[30],"CML,":[32],"a":[33,73],"second":[34],"generation":[35],"inhibitors,":[37],"nilotinib":[38],"dasatinib,":[40],"now":[42],"gained":[43],"CML.":[49],"Notably,":[50],"these":[51],"second-generation":[52],"are":[54,110],"active":[55],"many":[57],"mutations":[60],"kinase":[64],"that":[65,109],"confer":[66],"resistance":[67,71],"to":[68],"imatinib.":[69],"However,":[70],"remains":[72],"major":[74],"problem,":[75],"new":[77,118],"such":[79],"as":[80],"ponatinib":[81],"GNF2/GNF5":[83],"have":[84,145],"been":[85,146],"developed,":[86],"activity":[88],"towards":[89],"common":[91],"gatekeeper":[92],"T315I":[93],"mutation.":[94],"We":[95],"review":[96],"here":[97],"mechanisms":[99],"inhibition":[102],"an":[104,150],"emphasis":[105],"on":[106,124],"structural":[107,141],"elements":[108,142],"important":[111],"selectivity":[114],"design":[116],"molecules.":[119],"In":[120],"particular,":[121],"we":[122],"focus":[123],"how":[125],"changes":[126],"conformation":[129],"P-loop,":[132],"activation":[134],"loop,":[135],"DFG":[137],"motif,":[138],"other":[140],"instrumental":[147],"developing":[149],"understanding":[151],"inhibitor":[153],"binding.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2041263286","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
